Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Ailani · SciRah

Researcher profile · Semantic Scholar

J. Ailani

Share profile

J. Ailani — researcher profile on SciRah

h-index: 31
Works: 173
Citations: 4,701

Most-cited papers

Atogepant for the Preventive Treatment of Migraine.
J. Ailani, R. Lipton, P. Goadsby, Hua Guo +4 more
2021New England Journal of Medicine224 citations Open access
Semantic Scholar
Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
P. Winner, P. McAllister, G. Chakhava, J. Ailani +5 more
2021Journal of the American Medical Association (JAMA)89 citations Open access
Semantic Scholar
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
P. Pozo-Rosich, J. Ailani, M. Ashina, P. Goadsby +13 more
2023The Lancet87 citations
Semantic Scholar
Pharmacovigilance: reporting requirements throughout a product’s lifecycle
S. Lucas, J. Ailani, T. Smith, Ahmad M. Abdrabboh +2 more
2022Therapeutic Advances in Drug Safety79 citations Open access
Semantic Scholar
Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data
D. Dodick, S. Tepper, J. Ailani, N. Pannacciulli +7 more
2021Headache55 citations Open access
Semantic Scholar
Percutaneous Interventional Strategies for Migraine Prevention: A Systematic Review and Practice Guideline.
M. Barad, J. Ailani, S. Hakim, N. Kissoon +1 more
2021Pain medicine (Malden, Mass.)47 citations
Semantic Scholar
Temporomandibular Joint Disorder Comorbidities.
Davis C. Thomas, J. Khan, D. Manfredini, J. Ailani
2023Dental Clinics of North America37 citations Open access
Semantic Scholar
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine—Clinical Considerations
J. Ailani, E. Kaiser, Paul G. Mathew, P. McAllister +7 more
2022Neurology35 citations Open access
Semantic Scholar
Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome
R. Lipton, D. Dodick, J. Ailani, Lora Mcgill +2 more
2021Headache34 citations Open access
Semantic Scholar
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial
P. Goadsby, J. Ailani, D. Dodick, Amaal J. Starling +6 more
2025Nature Medicine25 citations Open access
Semantic Scholar
Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
J. Ailani, Liron Rabany, S. Tamir, Alon Ironi +1 more
2022Frontiers in Pain Research25 citations Open access
Semantic Scholar
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group
T. Schwedt, Amynah A. Pradhan, Michael L. Oshinsky, Mitchell F. Brin +19 more
2024Headache24 citations
Semantic Scholar
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review
B. Raffaelli, R. De Icco, Michele Corrado, Maria Terhart +1 more
2023Cephalalgia23 citations Open access
Semantic Scholar
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
J. Ailani, P. McAllister, P. Winner, G. Chakhava +5 more
2022BMC Neurology20 citations Open access
Semantic Scholar
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data
D. Kudrow, R. Dafer, D. Dodick, Amaal J. Starling +7 more
2023Headache19 citations Open access
Semantic Scholar
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis
C. Tassorelli, K. Onishchenko, Rashmi B. Halker Singh, Molly Duan +7 more
2024Cephalalgia18 citations Open access
Semantic Scholar
Hemiplegic Migraine
Arathi S. Nandyala, T. Shah, J. Ailani
2023Current Neurology and Neuroscience Reports18 citations
Semantic Scholar
Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine
Andrew M. Blumenfeld, R. Boinpally, Rosa L. De Abreu Ferreira, Joel M. Trugman +3 more
2023Headache18 citations Open access
Semantic Scholar
Patient preference for early onset of efficacy of preventive migraine treatments
J. Ailani, P. Winner, A. Hartry, T. Brevig +5 more
2022Headache18 citations Open access
Semantic Scholar
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks
R. Lipton, J. Ailani, Kathleen Mullin, Jelena M. Pavlović +3 more
2024Headache14 citations Open access
Semantic Scholar
Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study
J. Ailani, R. Lipton, Andrew M. Blumenfeld, Laszlo Mechtler +6 more
2024Headache13 citations Open access
Semantic Scholar
Photophobia is associated with lower sleep quality in individuals with migraine: results from the American Registry for Migraine Research (ARMR)
Nina Sharp, Mark J. Burish, Kathleen B. Digre, J. Ailani +3 more
2024The Journal of Headache and Pain12 citations Open access
Semantic Scholar
A retrospective evaluation of the combination of erenumab and onabotulinum toxin A for the prevention of chronic migraine.
Arathi S. Nandyala, Himanshu Suri, C. Dougherty, J. Ailani
2022Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)12 citations
Semantic Scholar
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
P. McAllister, P. Winner, J. Ailani, D. Buse +7 more
2022The Journal of Headache and Pain12 citations Open access
Semantic Scholar
Does “wearing off” of efficacy occur in galcanezumab‐treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials
J. Ailani, Dulanji K. Kuruppu, M. Rettiganti, T. Oakes +4 more
2022Headache12 citations Open access
Semantic Scholar
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
P. Rizzoli, M. Marmura, Jennifer V. Robblee, J. McVige +8 more
2024The Journal of Headache and Pain11 citations Open access
Semantic Scholar
The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review
J. Ailani, Stephanie J. Nahas, D. Friedman, Todd Kunkel
2023Pain and Therapy11 citations Open access
Semantic Scholar
Raynaud's phenomenon associated with calcitonin gene‐related peptide receptor antagonists case report
Kate Bedrin, J. Ailani, C. Dougherty
2022Headache11 citations
Semantic Scholar
Timing and durability of response to erenumab in patients with chronic migraine
S. Tepper, S. Lucas, M. Ashina, T. Schwedt +6 more
2021Headache11 citations Open access
Semantic Scholar
Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis
B. Peterlin, D. Bond, J. Ailani, D. Dodick +6 more
2024Cephalalgia10 citations Open access
Semantic Scholar
Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysis
E. MacGregor, Susan Hutchinson, Hongxin Lai, B. Dabruzzo +3 more
2023Headache10 citations Open access
Semantic Scholar
Tracking Migraine Digitally: The Future of Migraine Management
M. Bensink, Shweta N. Shah, N. Shah, P. Desai +6 more
202110 citations Open access
Semantic Scholar
Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial (S47.002)
P. Goadsby, J. Ailani, D. Dodick, Amaal J. Starling +5 more
2023Thursday, April 279 citations
Semantic Scholar
Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations
S. Tepper, Huma U. Sheikh, C. Dougherty, Stephanie J. Nahas +7 more
2022Headache9 citations Open access
Semantic Scholar
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle
D. Dodick, A. Blumenfeld, Rashmi B. Halker Singh, Rachel Williams +7 more
2022Headache8 citations Open access
Semantic Scholar
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
S. Tepper, J. Ailani, J. Ford, Russell M. Nichols +4 more
2022Clinical drug investigation8 citations Open access
Semantic Scholar
Rimegepant safety and patient-reported outcomes among triptan-naïve, triptan-using, and triptan-failure participants: Subgroup analysis of an open-label, multicenter study
J. Ailani, Jelena M. Pavlović, Glenn C. Pixton, Terence Fullerton
2025Cephalalgia7 citations Open access
Semantic Scholar
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
S. Tepper, D. Albrecht, J. Ailani, Louis C. Kirby +2 more
2024CNS Drugs7 citations Open access
Semantic Scholar
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial
M. Ashina, R. Lipton, J. Ailani, J. Versijpt +5 more
2023European Journal of Neurology7 citations Open access
Semantic Scholar
Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial (S47.005)
P. Pozo-Rosich, J. Ailani, M. Ashina, P. Goadsby +9 more
2023Thursday, April 277 citations
Semantic Scholar
Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial
Lauren C. Powell, Fiona O’Sullivan, Pramoda Jayasinghe, B. Rogula +5 more
2025The Journal of Headache and Pain6 citations Open access
Semantic Scholar
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
D. Dodick, S. Tepper, J. Ailani, Ani C Khodavirdi +6 more
2025Headache6 citations Open access
Semantic Scholar
Evaluation of rimegepant utilization patterns and patient characteristics among new users: a United States administrative claims-based study
J. Ailani, Motomori Lewis, Feng Dai, Aaron Jenkins +4 more
2024Current Medical Research and Opinion6 citations Open access
Semantic Scholar
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
J. Ailani, P. Gandhi, Anjana Lalla, Rashmi B. Halker Singh +6 more
2024Headache6 citations Open access
Semantic Scholar
The effect of treatment onset time on acute efficacy in migraine patients treating with remote electrical neuromodulation (REN)
J. Ailani, Istvan Tomaschek, A. Stark-Inbar, Sharon Shmuely +2 more
2025Cephalalgia5 citations Open access
Semantic Scholar
What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle
R. Lipton, J. Ailani, Andrew M. Blumenfeld
2024Neurological Therapeutics5 citations Open access
Semantic Scholar
Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene–related peptide monoclonal antibodies
J. Ailani, Anjana Lalla, Rashmi B. Halker Singh, Dagny Holle-Lee +5 more
2024Cephalalgia5 citations Open access
Semantic Scholar
Situational Prevention of Migraine Attacks: Can Early Treatment Change the Conversation?
Tulsi Shah, J. Ailani
2025Drugs3 citations
Semantic Scholar
Underdiagnosis and impact of menstrual migraine in real‐world clinical practice: A real‐world survey
G. Terwindt, J. Ailani, Jessica Cirillo, Lucy Abraham +9 more
2025Headache3 citations Open access
Semantic Scholar
CGRP Modulating Therapies: An Update
Kate Bedrin, Tulsi Shah, Shivani Vaidya, J. Ailani
2024Current Neurology and Neuroscience Reports3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Dodick×10
Invite
D. Dodick — researcher profile on SciRah
Joel M. Trugman×9
Invite
Joel M. Trugman — researcher profile on SciRah
S. Tepper×8
Invite
S. Tepper — researcher profile on SciRah
M. Ashina×6
Invite
M. Ashina — researcher profile on SciRah

Rosa L. De Abreu Ferreira

×5

Invite

Rosa L. De Abreu Ferreira — researcher profile on SciRah

Invite

Sung Yu — researcher profile on SciRah

Jonathan H. Smith×5

Invite

Jonathan H. Smith — researcher profile on SciRah

Invite

R. Lipton — researcher profile on SciRah

C. Dougherty×5

Invite

C. Dougherty — researcher profile on SciRah

Invite

B. Dabruzzo — researcher profile on SciRah

Invite

P. Goadsby — researcher profile on SciRah

Invite

M. Finnegan — researcher profile on SciRah